Article
Houston—The CustomVue refractive treatment (VISX/AMO) for patients with mixed astigmatism demonstrated good results at 6 months, according to Douglas D. Koch, MD.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.